Once the fastest-growing product category in cannabis, vapes were the focus of the industry’s first public health crisis with the appearance of E-cigarette and Vaping Product Associated Lung Injury (EVALI) in late summer 2019. Despite seeing ups and down in the first half of 2020, in part due to the impact of COVID-19, vape sales are on the rise again, and are likely to surpass summer 2019’s  peak in sales by the end of 2020. Sales of vapes fell off sharply after the announcement of the first EVALI-related death, which occurred on August 23, 2019. BDSA retail sales tracking data shows mon ..read more

Why Providing Market Forecasts, Retail Sales Tracking and Consumer Insights Makes BDSA the Most Reliable Data Source in the Industry There’s data everywhere. But how do you get to insightful and actionable data that drives business decisions and, more importantly, results? BDSA has a long-standing history of providing data to the cannabis industry. What makes us different? This post will delve into what makes BDSA‘s approach unique in the cannabis data analytics space. Our tagline, “Data. Deeper.” fits. “Data” identifies our core resource, the foundation of everything that we do. But data are ..read more

Cannabis consumers are a diverse group, as clearly demonstrated by BDSA’s consumer research. At the highest level, BDSA divides respondents into: Consumers: those who report consuming cannabis within the past six months, Acceptors: who do not currently consumer cannabis but are open to it, and Rejecters: who do not use cannabis and are not open to it. By performing a cluster analysis of consumer research conducted in the first quarter of 2020, BDSA was able to define market segments to help clients better understand cannabis consumers and make more informed business decisions. As cannabis le ..read more

When Colorado first launched adult-use (recreational) sales in 2014, the existing medical market opened up to a wave of new consumers, including those from the sizable illicit market as well as new consumers who previously had little or no experience with cannabis. The launch of adult-use sales in other U.S. states along with expanding medical programs have led to an increase in legal per capita sales across the U.S. at a 31% Compound Annual Growth Rate (CAGR) from 2013 to 2019. While the tremendous growth of the past six years is expected to slow, per capita sales are likely to increase for y ..read more

The popularity of CBD products has exploded in the U.S. in recent years, with sales in the U.S. cannabis dispensary channel alone rising from $8.4 million in May 2016 to $56.9 million in May 2020. And hemp-derived CBD products, containing less than 0.3% THC, are increasingly available via general retail channels, though CBD ingestibles are still officially off limits for sale in general retail channels in the U.S. and most other jurisdictions. The expansion of CBD product sales being dispensaries is taking place rapidly. BDSA forecasts the dispensary channel’s share of CBD sales to fall from 6 ..read more

The legal cannabis market has exploded in recent years, with sales in the U.S. reaching an estimated $12.4 billion in 2019, forecast to rise to $31 billion by 2024. The market for cannabidiol (CBD) has also grown rapidly, with U.S. sales totaling $2.6 billion in 2019, on track to reach $18 billion by 2024. While THC and CBD are the most widely known and marketed compounds found in Cannabis sativa, a few of the other 113 currently identified cannabinoids show potential for therapeutic and recreational applications and have attracted the attention of both researchers and those in the industry ..read more

Global legal cannabis spending is forecast to reach $47 billion in 2025, a number too big to ignore for many companies and industries. The U.S. will continue to be the largest global market, driven by more and more adult use markets opening. With the combination of more states enacting regulations allowing cannabis for medical and/or recreational use, and CBD products derived from hemp increasingly available in mainstream retail channels, consumers are growing more educated about cannabis. Today, more than 80% of the U.S. population agrees with some form of legalization, and that number is gro ..read more

Independence Day and cannabis go hand-in-hand: “daytime fun” and well as “celebrating special events” are top occasions for cannabis consumption. Cannabis sales spiked in the days surrounding the July 4th holiday in 2019, increasing 31% between July 1-3, and 21% between July 4-6. Although inhalable products – flower and concentrates – comprised the majority of sales in the days surrounding July 4th 2019, ingestible products experienced a boost in sales before and after the holiday, increasing 27% during July 1-6 – with candy experiencing the sharpest increase of 50% during the ..read more

BOULDER, CO and TORONTO, May 20, 2020 /CNW/ – BDSA (formerly BDS Analytics), the leader in comprehensive, accurate and actionable cannabis market intelligence and consumer research, announced today they have become the Official Insights Partner of Business of Cannabis. Business of Cannabis is the preeminent B2B cannabis media platform in Canada. As the Official Insights Partner, BDSA will provide Business of Cannabis with unique data and insights into cannabis consumers and markets across Canada with the goal of educating and supporting th ..read more

BDSA is pleased to announce the launch of Retail Sales Tracking for the state of Illinois! The initial launch of this data includes topline (category) level coverage of retail sales tracking for both adult-use and medical sales channels across Illinois between July 2019 and March 2020. Detailed coverage will be expanded within the months to come. Overview of Illinois Market: In the second half of 2019, medical sales in the Illinois market reached $ 147.6 million. In the first quarter of adult-use sales, revenues in the market reached $119.8 million. Roughly 38% of medical and adult-use sales ..read more